Breast Cancer Advice. Keep up to date with the latest information and treatment of breast cancer.
A Member of the Healthscout Network
 Printer Friendly  Send to a Friend

Anti-Estrogens Prevent Lung Cancer

Ivanhoe Broadcast News

(Ivanhoe Newswire) -- Anti-estrogen therapy for breast cancer may also reduce the risk of death from lung cancer.

"We found a reduction in lung cancer mortality among women treated with anti-estrogens for breast cancer," Elisabetta Rapiti, M.D., M.P.H., medical researcher with the Geneva Cancer Registry at the University of Geneva, Switzerland, was quoted as saying. "This work builds on previous studies that had suggested estrogens have a role in lung cancer development and progression."
 
To evaluate whether anti-estrogen therapy for breast cancer patients reduced their risk of subsequently developing and/or dying from lung cancer, Rapiti and colleagues studied 6,715 women living in the Geneva canton of Switzerland who were diagnosed with breast cancer between 1980 and 2003. Forty-six percent of the women received anti-estrogen therapy, primarily tamoxifen.

Advertisement
Related Stories
 border=
Selenium Helped Cells 'Reboot' After Exposure to Cancer-Causing Chemicals
Imaging Costs Soar for Medicare Cancer Patients
Breast Cancer Risks Not Same for Hispanic Women
Related Videos
 border=
Tracking Breast Cancer with Less Pain
5 Breast Cancer Myths
A Welcome Message from Survivor PJ Hamel
Related Slides
 border=
Breast Cancer
Breast Self-Exam

By the end of the study period, 40 cases of lung cancer had developed. Although there was no difference in the incidence of developing lung cancer among women with or without anti-estrogens, the risk of dying from lung cancer was significantly lower among women who received anti-estrogen therapy.

"Our results are particularly relevant to the research agenda exploring endocrine treatment(s) for lung cancer," said Rapiti. "If prospective studies confirm our results and find that anti-estrogen agents improve lung cancer outcomes, this could have substantial implications for clinical practice."

SOURCE: Presented at the CTRC-AACR San Antonio Breast Cancer Symposium, December 9-13, 2009



If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Melissa Medalie at mmedalie@ivanhoe.com

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.


Last updated 12/14/2009



Disclaimer: The information provided on this website is for educational purposes only and does not serve as a replacement for care provided by your own personal health care team. This website does not render or provide medical advice, and no individual should make any medical decisions or change their health behavior based on information provided here. All pertinent content provided on this website should be discussed with your personal physician to evaluate whether it has any relevance to or impact on your specific condition. Reliance on any information provided by this website is solely at your own risk.


May 1, 2010
Home
Search
Powered By HealthLine
New! For timely and trustworth health information, expert advice and much more, visit Breast Cancer Connection
Patient Guide
News
Health Videos
Health Encyclopedia
Health News Archive
Affiliate Information
HealthScout Network
Contact Us
Newsletters
Privacy Policy
Terms of Use

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service  

To find more information on specific conditions, please visit our partner sites: